🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06354712
Recruiting Phase 2

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

NCT06354712 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 2
Started
2024-04-04
Last updated
2025-01-15

Condition(s) studied

Oral Mucositis (Ulcerative) Due to Radiation

Investigational drug(s) / intervention(s)

N-Acetyl-Cysteine with Institutional standard careInstitutional standard care

N-Acetyl-Cysteine with Institutional standard care: A potent antioxidant and anti-inflammatory drug (A precursor of the endogenous antioxidant glutathione)

Institutional standard care: Benzydamine Mouthwash

Study summary

A prospective, randomized, controlled, parallel clinical trial will be conducted at Clinical Oncology and Nuclear Medicine Center at Mansoura University Hospital to assess the efficacy of N-acetylcysteine in the prevention of radiotherapy induced oral mucositis in Head and Neck cancer patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Adults \>18 years diagnosed with squamous cell carcinoma of the head and neck scheduled to receive curative radiotherapy (Primary or postoperative) of at least 50 Gy with or without concurrent chemotherapy. 2. Individuals with healthy mucosa. 3. Adequate bone marrow function (Hemoglobin level ≥10 g/dL, platelet count ≥75 × 103/microliter, and absolute neutrophil count ≥1.5 × 103/microliter). 4. Patients with ECOG performance ≤2 Exclusion Criteria: 1. History of chemotherapy or radiotherapy. 2. Signs of systemic infections. 3. Pregnant and lactating women. 4. Individuals receiving systemic analgesics. 5. Liver disorders and renal failure with eGFR \<30 ml/min/1.73m2 (by the MDRD equation). 6. Inability to follow instructions and complete the questionnaires.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinical Oncology and Nuclear Medicine of Mansoura University Hospital Al Mansurah Egypt Recruiting

More Mansoura University trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06354712 on ClinicalTrials.gov ↗ ← All trials in Egypt